UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?

BMC infectious diseases, 2011-12, Vol.11 (1), p.356-356, Article 356

2011

Volltextzugriff (PDF)

HIV-1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment

The Journal of infectious diseases, 2010-12, Vol.202 (12), p.1819-1825

2010

Volltextzugriff (PDF)

Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients

PloS one, 2014-02, Vol.9 (2), p.e88591-e88591

2014

Volltextzugriff (PDF)

Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection

PLoS pathogens, 2015-03, Vol.11 (3), p.e1004720-e1004720

2015

Volltextzugriff (PDF)

Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment

PloS one, 2016-06, Vol.11 (6), p.e0157160-e0157160

2016

Volltextzugriff (PDF)

Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection

PloS one, 2014-12, Vol.9 (12), p.e116081-e116081

2014

Volltextzugriff (PDF)

Antiretroviral Therapy and Central Nervous System HIV Type 1 Infection

The Journal of Infectious Diseases, 2008-05, Vol.197 (Supplement-3), p.S294-S306

2008

Volltextzugriff (PDF)

Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance

PloS one, 2020-07, Vol.15 (7), p.e0236162-e0236162

2020

Volltextzugriff (PDF)

Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression

PloS one, 2021-05, Vol.16 (5), p.e0250987-e0250987

2021

Volltextzugriff (PDF)

Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia

PLoS pathogens, 2009-04, Vol.5 (4), p.e1000395-e1000395

2009

Volltextzugriff (PDF)

Progressive multifocal leukoencephalopathy in HIV-1 infection

The Lancet infectious diseases, 2009-10, Vol.9 (10), p.625-636

2009

Volltextzugriff (PDF)

Neuroimmunology of CNS HIV Infection: A Narrative Review

Frontiers in neurology, 2022-06, Vol.13, p.843801-843801

2022

Volltextzugriff (PDF)

Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection

BMC neurology, 2021-12, Vol.21 (1), p.494-494, Article 494

2021

Volltextzugriff (PDF)

Raltegravir cerebrospinal fluid concentrations in HIV-1 infection

PloS one, 2009-09, Vol.4 (9), p.e6877-e6877

2009

Volltextzugriff (PDF)

Correction: Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection

BMC neurology, 2022-05, Vol.22 (1), p.197-197, Article 197

2022

Volltextzugriff (PDF)

Prevalence of CXCR4 Tropism among Antiretroviral-Treated HIV-1–Infected Patients with Detectable Viremia

The Journal of infectious diseases, 2006-10, Vol.194 (7), p.926-930

2006

Volltextzugriff (PDF)

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

BMC neurology, 2009-12, Vol.9 (1), p.63-63, Article 63

2009

Volltextzugriff (PDF)

CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series

Neurology, 2021-01, Vol.96 (2), p.e294

2021

Volltextzugriff (PDF)

Greater Risk of Stroke of Undetermined Etiology in a Contemporary HIV-Infected Cohort Compared with Uninfected Individuals

Journal of stroke and cerebrovascular diseases, 2017-05, Vol.26 (5), p.1154-1160

2017

Volltextzugriff (PDF)

Elevated Cerebrospinal Fluid Neurofilament Light Protein Concentrations Predict the Development of AIDS Dementia Complex

The Journal of infectious diseases, 2007-06, Vol.195 (12), p.1774-1778

2007

Volltextzugriff (PDF)

Treatment Benefit on Cerebrospinal Fluid HIV‐1 Levels in the Setting of Systemic Virological Suppression and Failure

The Journal of infectious diseases, 2006-12, Vol.194 (12), p.1686-1696

2006

Volltextzugriff (PDF)

Elevated Cerebrospinal Fluid Anti-CD4 Autoantibody Levels in HIV Associate with Neuroinflammation

Microbiology spectrum, 2022-02, Vol.10 (1), p.e0197521-e0197521

2022

Volltextzugriff (PDF)

Neurochemical biomarkers to study CNS effects of COVID‐19: A narrative review and synthesis

Journal of neurochemistry, 2021-10, Vol.159 (1), p.61-77

2021

Volltextzugriff (PDF)

Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls

Expert review of molecular diagnostics, 2017-08, Vol.17 (8), p.761-770

2017

Volltextzugriff (PDF)

1 – 25 von 1.076

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(961)
Mit Volltextzugriff
(875)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?

HIV-1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment

Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients

Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection

Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment

Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection

Antiretroviral Therapy and Central Nervous System HIV Type 1 Infection

Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance

Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression

Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia

Progressive multifocal leukoencephalopathy in HIV-1 infection

Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction

Neuroimmunology of CNS HIV Infection: A Narrative Review

Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection

Raltegravir cerebrospinal fluid concentrations in HIV-1 infection

Correction: Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection

Prevalence of CXCR4 Tropism among Antiretroviral-Treated HIV-1–Infected Patients with Detectable Viremia

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series

Greater Risk of Stroke of Undetermined Etiology in a Contemporary HIV-Infected Cohort Compared with Uninfected Individuals

Elevated Cerebrospinal Fluid Neurofilament Light Protein Concentrations Predict the Development of AIDS Dementia Complex

Treatment Benefit on Cerebrospinal Fluid HIV‐1 Levels in the Setting of Systemic Virological Suppression and Failure

Elevated Cerebrospinal Fluid Anti-CD4 Autoantibody Levels in HIV Associate with Neuroinflammation

Neurochemical biomarkers to study CNS effects of COVID‐19: A narrative review and synthesis

Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls

Aktive Filter

Suchergebnisse filtern